
Comprehensive Genetic Test Guides Prescribing of a Transplant Anti-Rejection Drug: Jessica Wright, Pharm.D., BCACP
Failed to add items
Add to Cart failed.
Add to Wish List failed.
Remove from wishlist failed.
Adding to library failed
Follow podcast failed
Unfollow podcast failed
-
Narrated by:
-
By:
About this listen
Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after non-liver organ transplants. Optimal tacrolimus levels are one of the important factors in survival of the transplanted organ.
(00:32)
Could you provide us a with little bit about your background and yourself?
(03:45)
Will you please provide a brief overview of Mayo test 3A5Q?
(06:56)
Which patients should have this testing, and when should it be performed?
(08:15)
What alternative or complementary tests should be considered?
(09:25)
How are the results used in patient care?
(10:38)
Will you help the audience understand the significance of monitoring tacrolimus levels for transplant rejection?
(12:53)
What alleles are included in this test?